Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis-Reference-Cited by-同舟云学术

Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis

Published:2016-07 Issue:1 Volume:75 Page:99-105
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Bissonnette Robert,Pariser David M.,Wasel Norman R.,Goncalves Joana,Day Robert M.,Chen Rongdean,Sebastian Michael

Publisher

Elsevier BV

Subject

Dermatology

Reference24 articles.

1. Pathogenesis and therapy of psoriasis;Lowes;Nature,2007

2. The roles of cells and cytokines in the pathogenesis of psoriasis;Coimbra;Int J Dermatol,2012

3. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study;Brunasso;Br J Dermatol,2013

4. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients;Adisen;J Eur Acad Dermatol Venereol,2009

5. Palmoplantar lesions in psoriasis: a study of 3065 patients;Kumar;Acta Derm Venereol,2002

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palmoplantar psoriasis: A clinicopathological correlation in a tertiary care hospital;Skin Research and Technology;2024-08

2. Efficacy of apremilast in hyperkeratotic hand and foot dermatitis: results from a randomized observer‐blinded comparative study;International Journal of Dermatology;2024-05-17

3. Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis;American Journal of Clinical Dermatology;2024-03-04

4. Comparative evaluation of efficacy and tolerability of apremilast and methotrexate in patients of moderate-to-severe palmoplantar psoriasis: A randomized, parallel, open-label clinical trial;Indian Journal of Pharmacology;2023-11

5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12